Light chain amiloydosis: Clinical, laboratory characteristics and treatment approach

Light chain amiloydosis: Clinical, laboratory characteristics and treatment approach

Introduction: Light chain amyloidosis (AL) is a plasma cell neoplasia characterized by deposition of a pathological insoluble fibrillary protein, i.e. light chain immunoglobulin. Aim: To show clinical and laboratory characteristics of patients, course, treatment modalities, prognosis etc. Material a...

Full description

Bibliographic Details
Main Authors:	Stanković Ana, Lazarević Milana, Srdić Sara, Sretenović Aleksandra
Format:	Article
Language:	English
Published:	University of Belgrade, Medical Faculty 2021-01-01
Series:	Medicinski Podmladak
Subjects:	amyloidosis treatment prognosis
Online Access:	https://scindeks-clanci.ceon.rs/data/pdf/0369-1527/2021/0369-15272104040S.pdf

Similar Items

The Landscape of Cytogenetic Aberrations in Light-Chain Amyloidosis with or without Coexistent Multiple Myeloma
by: Haiyan He, et al.
Published: (2023-02-01)

Monitoring Patients with Light Chain (AL) Amyloidosis during and after Therapy: Response Assessment and Identification of Relapse
by: Paolo Milani, et al.
Published: (2022-01-01)

Cardiovascular toxicity from therapies for light chain amyloidosis
by: Paolo Morfino, et al.
Published: (2023-07-01)

Critical Management Strategies for Cardiovascular Involvementin Light Chain Amyloidosis
by: SHI Yunjing, et al.
Published: (2023-01-01)

Editorial: Proceedings and predictions in cardiac amyloidosis: unsolved mysteries and challenges for the future
by: Aldostefano Porcari, et al.
Published: (2023-07-01)

What is new in amyloidosis treatment? Part 1: Light chains
by: Gisela Bendelman, et al.
Published: (2023-12-01)

How I manage systemic light chain amyloidosis
by: Gregory P. Kaufman, et al.
Published: (2021-09-01)

The short and long‐term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy
by: Osnat Itzhaki Ben Zadok, et al.
Published: (2023-06-01)

Physiology, Diagnosis and Treatment of Cardiac Light Chain Amyloidosis
by: Agnieszka Stelmach-Gołdyś, et al.
Published: (2022-02-01)

Extensive Amyloid Purpura: An Unusual Presentation of Myeloma-associated Light Chain Amyloidosis
by: Nor Fazil Jaber, et al.
Published: (2023-06-01)

Standardising Care and Treatment of Transthyretin Amyloid Cardiomyopathy
by: Marianna Fontana, et al.
Published: (2023-11-01)

Localized Gastric Amyloidosis with Kappa and Lambda Light Chain Co-Expression
by: Yong Hwan Ahn, et al.
Published: (2018-05-01)

Monoclonal Gammopathies of Clinical Significance: A Critical Appraisal
by: Rafael Ríos-Tamayo, et al.
Published: (2022-10-01)

Prognostic Value of Holter Monitoring in Light Chain Amyloidosis
by: Yutong Sun, et al.
Published: (2023-12-01)

Diagnostic problems of rare diseases - amyloidosis. A case report
by: Hanna Senat, et al.
Published: (2024-02-01)

AL Amyloidosis and Multiple Myeloma: A Complex Scenario in Which Cardiac Involvement Remains the Key Prognostic Factor
by: Rafael Ríos-Tamayo, et al.
Published: (2023-07-01)

Dysphagia due to systemic light chain amyloidosis revealed by videoendoscopic and videofluorographic swallowing examinations
by: Masafumi Ohki, et al.
Published: (2018-03-01)

Impact of Non-Cardiac Clinicopathologic Characteristics on Survival in Transthyretin Amyloid Polyneuropathy
by: Alejandra González‐Duarte, et al.
Published: (2020-03-01)

Recognizing Pinch Purpura as the First Manifestation of Light-chain Amyloidosis
by: Erman Öztürk, et al.
Published: (2018-08-01)

Alterations of the gut microbiota in patients with immunoglobulin light chain amyloidosis
by: Jipeng Yan, et al.
Published: (2022-10-01)

Prognostic Value of N-Terminal Pro-Brain Natriuretic Peptide and High-Sensitivity Troponin T Levels in the Natural History of Transthyretin Amyloid Cardiomyopathy and Their Evolution after Tafamidis Treatment
by: Silvia Oghina, et al.
Published: (2021-10-01)

The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
by: Emilia Czyżewska, et al.
Published: (2021-03-01)

Clinical features and predictors of atrial fibrillation in patients with light‐chain or transthyretin cardiac amyloidosis
by: Maria Papathanasiou, et al.
Published: (2022-06-01)

Clinical Profile and Prognosis of Hereditary Transthyretin Amyloid Cardiomyopathy: A Single-Center Study in South China
by: Shuai Wang, et al.
Published: (2022-06-01)

In-hospital mortality in amyloid light chain amyloidosis: analysis of the Premier Healthcare Database
by: Tiffany P Quock, et al.
Published: (2022-12-01)

The Clinical Characteristics of Immunoglobulin Light Chain Amyloidosis in the Chinese Population: A Systematic Scoping Review
by: Chengcheng Fu, et al.
Published: (2022-12-01)

Evaluation of a new ELISA assay for monoclonal free‐light chain detection in patients with cardiac amyloidosis
by: Hajer Abroud, et al.
Published: (2022-08-01)

Therapy and management of systemic AL (primary) amyloidosis
by: G Palladini, et al.
Published: (2006-11-01)

Modified Body Mass Index as a Novel Nutritional and Prognostic Marker in Patients with Cardiac Amyloidosis
by: Francesca Dongiglio, et al.
Published: (2022-04-01)

Cardiac Amyloidosis with Normal Wall Thickness: Prevalence, Clinical Characteristics and Outcome in a Retrospective Analysis
by: Daniella Nagy, et al.
Published: (2022-07-01)

Real world data on light chain cardiac amyloidosis: Still a delayed diagnosis
by: Sofia Chatzileontiadou, et al.
Published: (2022-10-01)

The prognostic value of multiparametric cardiac magnetic resonance in patients with systemic light chain amyloidosis
by: Fujia Miao, et al.
Published: (2023-05-01)

Waldenström macroglobulinemia presenting as nephrotic syndrome: Renal heavy and light chain amyloidosis
by: Arjan J. Kwakernaak, et al.
Published: (2022-05-01)

Hereditary systemic transthyretin amyloidosis: a clinical case and an opinion on the problem
by: A. S. Draganova, et al.
Published: (2019-07-01)

Dermoscopic Features of Lichen Amyloidosis in Caucasians—A Case Series and Literature Review
by: Magdalena Żychowska, et al.
Published: (2021-09-01)

Systemic amyloidosis journey from diagnosis to outcomes: a twelve-year real-world experience of a single center in a middle-income country
by: Roberta Shcolnik Szor, et al.
Published: (2022-12-01)

Clinical characteristics and prognostic value of renal immune complex deposition in patients with light chain amyloidosis
by: Jipeng Yan, et al.
Published: (2022-10-01)

An early misdiagnosis of light chain amyloidosis: one case report with a literature review
by: Qiao-dan Zhou, et al.
Published: (2024-01-01)

Coexistence of Light Chain and Transthyretin Cardiac Amyloidosis
by: Abhishek Gami, MD, et al.
Published: (2024-04-01)

Prognostic value of native T1 and extracellular volume in patients with immunoglubin light-chain amyloidosis
by: Yumeng Liu, et al.
Published: (2024-02-01)